Vanadyl Nanocomplexes Enhance Photothermia-Induced Cancer Immunotherapy to Inhibit Tumor Metastasis and Recurrence

Doudou Hu,Hongxia Xu,Wei Zhang,Xiaodan Xu,Bing Xiao,Xueying Shi,Zhuxian Zhou,Nigel K. H. Slater,Youqing Shen,Jianbin Tang
DOI: https://doi.org/10.1016/j.biomaterials.2021.121130
IF: 14
2021-01-01
Biomaterials
Abstract:Conventional photothermal therapy (PTT) is insufficient to induce a strong and potent anti-tumor immune response. Herein, we present a vanadyl nanocomplex, which simultaneously serves as a photothermal agent (PTA) and an immunogenic cell death (ICD) inducer to enhance the anti-tumor immunity of PTT. The vanadyl nanocomplex (STVN) is constructed via facile one-step coordination assembly under ambient conditions. STVN not only has a strong and stable photothermal effect under near-infrared (NIR) irradiation, but also can cause severe endoplasmic reticulum (ER) stress by itself, leading to ICD and activating the systemic immune responses. In the absence of any adjuvants, NIR-irradiated STVN almost completely ablates primary tumors and simultaneously inhibits distant tumors in mice bearing bilateral melanoma. Meanwhile, the intratumorally injected STVN combined with NIR effectively suppressed melanoma lung metastasis as well as tumor recurrence, displaying that local STVN-mediated PTT could trigger a systemic anti-tumor immunity. Therefore, STVN, as a novel immunogenicity-enhanced PTA, affords a "one stone two birds" strategy for improved photothermia-induced cancer immunotherapy.
What problem does this paper attempt to address?